CD8A and hepatocellular carcinoma: First conclusion, functional HBV-specific T cells (mainly CD8+ T cells since the use of 9–10-mer peptides) in PBMCs displayed an increased trend from CHB, LC, HCC to R phases (no statistical difference between LC and HCC), and also from IA, IT to IC phases of CHB (no statistical difference between IT and IC).